Teradyne CEO’s 10b5‑1 Sales Show Prudent Liquidity, Not Weakness
Teradyne CEO Gregory Smith’s latest 10b5‑1 sale shows disciplined liquidity planning, not a warning sign—insightful for investors and security teams alike.
4 minutes to read
TERADYNE INC